Highnoon Laboratories Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Highnoon Laboratories Limited with three other
pharmaceutical manufacturers in Asia:
Zhejiang Xinguang Pharmaceutical Co Ltd
sales of 310.87 million Chinese Renmimbi [US$44.72 million]
of which 100%
was Pharmaceutical manufacturing industry),
Sinil Pharmaceutical Co Ltd
of South Korea
(50.94 billion Korean Won [US$44.98 million]
DHP Korea Co Ltd
based in South Korea
(49.81 billion Korean Won [US$43.98 million]
Highnoon Laboratories Limited reported sales of 5.97 billion Pakistan Rupees (US$44.43 million)
December of 2017.
increase of 17.8%
versus 2016, when the company's sales were 5.07 billion Pakistan Rupees.
Sales at Highnoon Laboratories Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 142%).